Oviduct patency control by means of 133Xe-solution.
The authors describe a radioisotopic method for the oviduct patency control in patients suffering from primary or secondary sterility. The application of 133Xe causes at least about 3-4 times less radiation than hysterosalpingographical tests. Ease of interpretation facility, painlessness and comparability of the results were noticed.
D000328:Adult; D005186:Fallopian Tube Patency Tests / Q000379:methods*; D005260:Female; D006801:Humans; D007047:Hysterosalpingography; D011829:Radiation Dosage; D011865:Radioisotope Dilution Technique; D014980:Xenon Radioisotopes
D014980:Xenon Radioisotopes